What is the address of DEMONSEAU MEDICAL?

The registered office of DEMONSEAU MEDICAL is located at Rue des Hurchets 29, 5140 Sombreffe.

Is DEMONSEAU MEDICAL still active?

Yes. According to the CBE (17 September 2026) DEMONSEAU MEDICAL is active, legal situation “Normale toestand”, started on 15 September 2023.

Is DEMONSEAU MEDICAL registered on Peppol?

No, DEMONSEAU MEDICAL is currently not registered on the Peppol network.

What is the enterprise number of DEMONSEAU MEDICAL?

The enterprise number of DEMONSEAU MEDICAL is BE0805875604.

When was DEMONSEAU MEDICAL founded?

DEMONSEAU MEDICAL was founded on 15 September 2023.

Who are the directors of DEMONSEAU MEDICAL?

According to the 2025 annual accounts, the directors of DEMONSEAU MEDICAL are: MANON DEMONSEAU.

Is DEMONSEAU MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 September 2023; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DEMONSEAU MEDICAL make in 2025?

DEMONSEAU MEDICAL posted a profit after taxes of € 12,966 in financial year 2025.

What is the revenue of DEMONSEAU MEDICAL?

As a small company, DEMONSEAU MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 21,217.

DEMONSEAU MEDICAL (Private Limited) - Sombreffe

Dossier DEMONSEAU MEDICAL, printed on 17 September 2026 from databakkes.be/en/0805875604/demonseau-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DEMONSEAU MEDICAL from Sombreffe, company number BE0805875604, closed financial year 2025 with a result of € 12,966 after tax. For that financial year DEMONSEAU MEDICAL recorded a gross margin of € 21,217 and equity of € 46,879. Compared with financial year 2024, the result moved from € 69,913 to € 12,966. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Healthy

€ 46,879

▼ 30% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 12,966

▼ 81% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 71,223

▲ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 32,857 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,517

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,905

▲ € 3,359 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 27,188

▲ 24% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 94,241 Gross margin 2024: € 94,241 First fiscal year in the series	€ 21,217 Gross margin 2025: € 21,217 ▼ 77% vs 2024 (€ 94,241) Unfavourable step	▼ 77%
Profit after taxes	€ 69,913 Profit after taxes 2024: € 69,913 First fiscal year in the series	€ 12,966 Profit after taxes 2025: € 12,966 ▼ 81% vs 2024 (€ 69,913) Unfavourable step	▼ 81%
Equity	€ 66,770 Equity 2024: € 66,770 First fiscal year in the series	€ 46,879 Equity 2025: € 46,879 ▼ 30% vs 2024 (€ 66,770) Unfavourable step	▼ 30%
Total debts	€ 27,421 Total debts 2024: € 27,421 First fiscal year in the series	€ 36,090 Total debts 2025: € 36,090 ▲ 32% vs 2024 (€ 27,421) Unfavourable step	▲ 32%
Cash	€ 64,805 Cash 2024: € 64,805 First fiscal year in the series	€ 71,223 Cash 2025: € 71,223 ▲ 10% vs 2024 (€ 64,805) Favourable step	▲ 10%
Retained profit	€ 62,770 Retained profit 2024: € 62,770 First fiscal year in the series	€ 42,879 Retained profit 2025: € 42,879 ▼ 32% vs 2024 (€ 62,770) Unfavourable step	▼ 32%
Dividend	€ 7,143 Dividend 2024: € 7,143 First fiscal year in the series	€ 32,857 Dividend 2025: € 32,857 ▲ € 25,714 vs 2024 (€ 7,143) Unchanged	▲ € 25,714
Balance sheet total	€ 94,191 Balance sheet total 2024: € 94,191 First fiscal year in the series	€ 82,969 Balance sheet total 2025: € 82,969 ▼ 12% vs 2024 (€ 94,191) Unchanged	▼ 12%

Key figures of DEMONSEAU MEDICAL, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DEMONSEAU MEDICAL?

What happened at DEMONSEAU MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 12,966 (▼ 81% vs 2024). filed late Source: NBB ↗
Sep 15, 2023 New establishment in Sombreffe. KBO
2023 MANON DEMONSEAU became a director. NBB
Sep 15, 2023 Start of the company according to the CBE. KBO

In short

From € 69,913 profit in 2024 to € 12,966 profit in 2025.

Paid € 22,878 in corporate taxes since 2024.

Best year ever: 2024, with € 69,913 profit.

Paid out € 40,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DEMONSEAU MEDICAL? We notify you, reason included.

Follow DEMONSEAU MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit